These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26113688)

  • 21. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
    Hota P; Dass C; Kumaran M; Simpson S
    AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.
    Saito T; Takahashi H; Kaneda H; Binnie M; Azad S; Sato M; Waddell TK; Cypel M; Liu M; Keshavjee S
    Am J Transplant; 2013 Dec; 13(12):3192-201. PubMed ID: 24164971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The site and nature of airway obstruction after lung transplantation.
    Verleden SE; Vasilescu DM; Willems S; Ruttens D; Vos R; Vandermeulen E; Hostens J; McDonough JE; Verbeken EK; Verschakelen J; Van Raemdonck DE; Rondelet B; Knoop C; Decramer M; Cooper J; Hogg JC; Verleden GM; Vanaudenaerde BM
    Am J Respir Crit Care Med; 2014 Feb; 189(3):292-300. PubMed ID: 24354907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.
    Weigt SS; Kim GJ; Jones HD; Ramsey AL; Amubieya O; Abtin F; Pourzand L; Lee J; Shino MY; DerHovanessian A; Stripp B; Noble PW; Sayah DM; Saggar R; Britton I; Lynch JP; Belperio JA; Goldin J
    Transplantation; 2022 Jun; 106(6):1253-1261. PubMed ID: 34534193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
    Snell GI; Paraskeva M; Westall GP
    Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
    Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
    J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.
    Vandermeulen E; Lammertyn E; Verleden SE; Ruttens D; Bellon H; Ricciardi M; Somers J; Bracke KR; Van Den Eynde K; Tousseyn T; Brusselle GG; Verbeken EK; Verschakelen J; Emonds MP; Van Raemdonck DE; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Int; 2017 Feb; 30(2):134-143. PubMed ID: 27933655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
    Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
    Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CT at onset of chronic lung allograft dysfunction in lung transplant patients predicts development of the restrictive phenotype and survival.
    Dettmer S; Shin HO; Vogel-Claussen J; Westphal M; Haverich A; Warnecke G; Welte T; Wacker F; Gottlieb J; Suhling H
    Eur J Radiol; 2017 Sep; 94():78-84. PubMed ID: 28647206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lung allograft dysfunction subtype analysis by computed tomography volumetry.
    Peräkylä LH; Raivio PM; Kesävuori RI; Piilonen AK; Stark CK; Halme MK; Nykänen AI
    Clin Transplant; 2022 Jan; 36(1):e14507. PubMed ID: 34634164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction.
    Sacreas A; Taupin JL; Emonds MP; Daniëls L; Van Raemdonck DE; Vos R; Verleden GM; Vanaudenaerde BM; Roux A; Verleden SE;
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31439680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.
    Veraar C; Kliman J; Benazzo A; Oberndorfer F; Laggner M; Hacker P; Raunegger T; Janik S; Jaksch P; Klepetko W; Ankersmit HJ; Moser B
    Sci Rep; 2021 Mar; 11(1):6799. PubMed ID: 33762606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.